Your session is about to expire
← Back to Search
Sonobiopsy for Glioblastoma
Study Summary
This trial is important because it will help doctors understand how to best treat brain tumors by looking at their molecular features. Sonobiopsy has the potential to become a standard tool for diagnosing and managing brain tumors, which could dramatically improve patient outcomes.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am 18 years old or older.I am scheduled for surgery to remove my tumor.I have a recurring brain tumor confirmed by a recent MRI and am planning surgery.I do not have any recent serious heart or lung problems.My brain lesion is near the surface and in the upper part of my brain.I have a history of cancer or have undergone cancer treatment.I was recently diagnosed with a brain tumor, suspected to be glioblastoma, based on a scan done within the last 28 days.My cancer is low grade or has spread to other parts of my body.I have had brain surgery before.I do not have scalp or skin conditions that interfere with ultrasound use.I have a physical defect in my skull.I am already in a clinical trial that involves treatment before surgery.My brain tumor has come back or I have tissue damage from radiation.My lesion lights up with a special dye in MRI scans.
- Group 1: Sonobiopsy
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants are currently taking part in this research study?
"Affirmative. The clinicaltrial.gov registry states that this research program is actively seeking participants and was first listed on April 16th 2022. To date, the trial has enrolled 20 individuals at a single medical center."
Is enrollment in this experiment ongoing?
"Confirmation of active recruitment is available on clinicaltrials.gov; this trial was initially made public on April 16th 2022 and the most recent update occurred September 21st of the same year."
Share this study with friends
Copy Link
Messenger